# Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease

> **NCT06515106** · NA · RECRUITING · sponsor: **Fundacion Clinic per a la Recerca Biomédica** · enrollment: 20 (estimated)

## Conditions studied

- Limbic Encephalitis With LGI1 Antibodies

## Interventions

- **BEHAVIORAL:** Remote cognitive rehabilitation program

## Key facts

- **NCT ID:** NCT06515106
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-18
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06515106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06515106, "Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06515106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*